These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 32343013)

  • 21. COVID-19 pandemic & head and neck cancer patients management: The role of virtual multidisciplinary team meetings.
    Salari A; Shirkhoda M
    Oral Oncol; 2020 Jun; 105():104693. PubMed ID: 32291153
    [No Abstract]   [Full Text] [Related]  

  • 22. The impact of comorbidity on outcome in 12 623 Danish head and neck cancer patients: a population based study from the DAHANCA database.
    Bøje CR; Dalton SO; Grønborg TK; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Overgaard J
    Acta Oncol; 2013 Feb; 52(2):285-93. PubMed ID: 23320773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Navigating the impact of COVID-19 on palliative care for head and neck cancer.
    Singh AG; Deodhar J; Chaturvedi P
    Head Neck; 2020 Jun; 42(6):1144-1146. PubMed ID: 32338809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Head and neck cancer care in the COVID-19 pandemic: A brief update.
    Yuen E; Fote G; Horwich P; Nguyen SA; Patel R; Davies J; Houlton J; Nathan CA; St John M; Day T
    Oral Oncol; 2020 Jun; 105():104738. PubMed ID: 32345570
    [No Abstract]   [Full Text] [Related]  

  • 25. Preliminary Estimates of the Prevalence of Selected Underlying Health Conditions Among Patients with Coronavirus Disease 2019 - United States, February 12-March 28, 2020.
    CDC COVID-19 Response Team
    MMWR Morb Mortal Wkly Rep; 2020 Apr; 69(13):382-386. PubMed ID: 32240123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival analysis of head and neck squamous cell carcinoma: influence of smoking and drinking.
    Farshadpour F; Kranenborg H; Calkoen EV; Hordijk GJ; Koole R; Slootweg PJ; Terhaard CH
    Head Neck; 2011 Jun; 33(6):817-23. PubMed ID: 20737489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Nonsteroidal Anti-inflammatory Drug Use With Survival in Patients With Squamous Cell Carcinoma of the Head and Neck Treated With Chemoradiation Therapy.
    Iovoli AJ; Hermann GM; Ma SJ; Platek AJ; Farrugia MK; Yau E; Wooten KE; Arshad H; Gupta V; Kuriakose MA; Hicks WL; Singh AK
    JAMA Netw Open; 2020 Jun; 3(6):e207199. PubMed ID: 32602907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comorbidity is an independent predictor of health-related quality of life in a longitudinal cohort of head and neck cancer patients.
    Østhus AA; Aarstad AK; Olofsson J; Aarstad HJ
    Eur Arch Otorhinolaryngol; 2013 May; 270(5):1721-8. PubMed ID: 23053388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Head and neck cancer: high-risk population for COVID-19.
    Yan F; Nguyen SA
    Head Neck; 2020 Jun; 42(6):1150-1152. PubMed ID: 32338797
    [No Abstract]   [Full Text] [Related]  

  • 30. COVID-19 and COPD.
    Leung JM; Niikura M; Yang CWT; Sin DD
    Eur Respir J; 2020 Aug; 56(2):. PubMed ID: 32817205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disproportionate impact of COVID-19 pandemic on head and neck cancer survivors.
    Adjei Boakye E; Jenkins W; Sharma A
    Head Neck; 2020 Jun; 42(6):1329-1331. PubMed ID: 32298019
    [No Abstract]   [Full Text] [Related]  

  • 32. Evaluation of comorbidity in 9388 head and neck cancer patients: a national cohort study from the DAHANCA database.
    Bøje CR; Dalton SO; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Overgaard J
    Radiother Oncol; 2014 Jan; 110(1):91-7. PubMed ID: 24412015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of risk factors for predicting the onset of symptoms in asymptomatic COVID-19 infected patients.
    Tao PY; Leng L; Liu K; Zhou RH; Hu YC; Wu SJ; Xiao YD; Liu J
    Int J Med Sci; 2020; 17(14):2187-2193. PubMed ID: 32922180
    [No Abstract]   [Full Text] [Related]  

  • 34. Management of primary skin cancer during a pandemic: Multidisciplinary recommendations.
    Baumann BC; MacArthur KM; Brewer JD; Mendenhall WM; Barker CA; Etzkorn JR; Jellinek NJ; Scott JF; Gay HA; Baumann JC; Manian FA; Devlin PM; Michalski JM; Lee NY; Thorstad WL; Wilson LD; Perez CA; Miller CJ
    Cancer; 2020 Sep; 126(17):3900-3906. PubMed ID: 32478867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population-Based Estimates of Chronic Conditions Affecting Risk for Complications from Coronavirus Disease, United States.
    Adams ML; Katz DL; Grandpre J
    Emerg Infect Dis; 2020 Aug; 26(8):1831-1833. PubMed ID: 32324118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Classical risk factors, but not HPV status, predict survival after chemoradiotherapy in advanced head and neck cancer patients.
    Descamps G; Karaca Y; Lechien JR; Kindt N; Decaestecker C; Remmelink M; Larsimont D; Andry G; Hassid S; Rodriguez A; Khalife M; Journe F; Saussez S
    J Cancer Res Clin Oncol; 2016 Oct; 142(10):2185-96. PubMed ID: 27370781
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence-Based Guidelines for Management of Head and Neck Mucosal Malignancies during the COVID-19 Pandemic.
    Crosby DL; Sharma A
    Otolaryngol Head Neck Surg; 2020 Jul; 163(1):16-24. PubMed ID: 32340549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epidemiology of head and neck squamous cell carcinoma not related to tobacco or alcohol.
    Curado MP; Boyle P
    Curr Opin Oncol; 2013 May; 25(3):229-34. PubMed ID: 23511666
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ethical framework for head and neck endocrine surgery in the COVID-19 pandemic.
    Chen AY; Shindo M
    Head Neck; 2020 Jul; 42(7):1418-1419. PubMed ID: 32400943
    [No Abstract]   [Full Text] [Related]  

  • 40. Comorbidity in head and neck cancer: Is it associated with therapeutic delay, post-treatment mortality and survival in a population-based study?
    Stordeur S; Schillemans V; Savoye I; Vanschoenbeek K; Leroy R; Macq G; Verleye L; De Gendt C; Nuyts S; Vermorken J; Beguin C; Grégoire V; Van Eycken L
    Oral Oncol; 2020 Mar; 102():104561. PubMed ID: 31918175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.